The Selebrek® CTO balloon dilation catheter has been approved by the National Medical Products Administration (NMPA) for going to market. This is the third coronary interventional balloon dilation catheter approved by NMPA after the PTCA balloon dilation catheter and NC PTCA balloon dilation catheter. Broaden the market of Kossel coronary intervention field, bring another sharp tool for clinical!

In January of this year, the CTO balloon catheter has already received FDA approval. The diameter of the tip entrance can reach 0.016”, Minimum balloon profile can reach 0.024”. Meanwhile, the spiral cutting design of hypotube effectively enhances the pushing ability of the catheter. Making it easy to pass through vessel stenosis, especially the occlusion.
Welcome to your inquiry and I will give you more details!